Pyramid Healthcare, Inc. Philadelphia, Pennsylvania, United States
Session Description: Historically, either psychotherapy, medication, or a combination of both was the recommended treatment protocol for behavioral health disorders. However, as our world continues to innovate so has behavioral health treatment, and now a third option has been gaining clinical traction. Specifically, in both the physical and mental health arenas, practitioners are seeing the advent of digital health devices, health and outcomes focused software, and applications collectively known as “Digital Therapeutics.”
A tremendous focus on research and development as well as the FDA publishing in 2017 the Digital Health Innovation Action Plan has provided a pathway for these Digital Therapeutics to launch clinically validated digital health devices.
This session will explore how a Behavioral Health System, eager to explore this new landscape, commenced a structured process to evaluate, select, and design a pilot program to measure the effectiveness of the identified digital therapeutic. Specifically, the presenters will take participants through the full process of digital therapeutic education, selection based on organizational needs, development of key performance indicators, review of the pilot program results, and how to best apply this information as they embark on their own digital therapeutic discovery journey.
Learning Objectives:
After this activity participants should be able to
Apply the knowledge gained from the digital therapeutics overview to determine if a digital therapeutic would add value to your practice
Identify at least two needs that could be addressed through the use of a digital therapeutic
Determine how the return on investment of the digital therapeutic will be measured